Basic Science and Pathogenesis

Myelin ensheathment is essential for rapid axonal electrical conduction, metabolic support and neuronal plasticity. In Alzheimer's disease (AD), disruptions in both myelin and axonal structures occur; however, the underlying mechanisms remain poorly understood.

To investigate the molecular and cellular mechanisms of myelin-axon disruption, we developed novel proximity labeling subcellular proteomics of the myelin-axon interface in postmortem human brains and AD-model mice. We developed new computational algorithm to uncover cell-cell-communication between myelin-axon and their disruption in AD humans. We applied super-resolution expansion microscopy and high-resolution confocal imaging to AD human postmortem brains and AD-model mice to reveal myelin-axon disruption and pathological changes.

Using proximity labeling subcellular proteomics of the myelin-axon interface in postmortem human brains and AD-model mice, we discovered dysregulated signaling pathways and ligand-receptor interactions, including those involved in β-amyloid processing, axonal outgrowth and lipid metabolism. Expansion microscopy confirmed the subcellular expression of top proteomic hits and revealed β-amyloid aggregation within internodal peri-axonal space and paranodal/juxtaparanodal channels. Although no overt changes in myelin coverage were observed, we found reduced paranode density and aberrant myelination and paranode positioning around amyloid plaque-associated dystrophic axons.

These findings highlight the myelin-axon interface as a critical site of protein aggregation and disrupted neuro-glial communication in AD. The molecular architecture of the myelin-axon interface uncovered in this study provides a foundation for future mechanistic investigations in health and disease.